Evaluation of the tuberculin skin test and the interferon- release assay for TB screening in French healthcare workers

Journal of Occupational Medicine and Toxicology

Volumn 4, Issue 1, 2009, Pages

  Tripodi, Dominique ^a   Brunet Courtois, Benedicte ^a   Nael, Virginie ^a   Audrain, Marie ^a   Chailleux, Edmond ^a   Germaud, Patrick ^a   Naudin, Frederique ^b   Muller, Jean Yves ^a   Bourrut Lacouture, Martine ^a   Durand Perdriel, Marie Henriette ^a   Gordeeff, Claire ^a   Guillaumin, Guyonne ^a   Houdebine, Marietherese ^a   Raffi, Francois ^a   Boutoille, David ^a   Biron, Charlotte ^a   Potel, Gilles ^a   Roedlich, Claude ^a   Geraut, Christian ^a   Schablon, Anja ^c   Nienhaus, Albert ^c   more..

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Tuberculosis Public Health Clinic   (France)

^c Accident Insurance and Prevention in the Health and Welfare Services   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ACID FAST BACTERIUM; ADULT; ARTICLE; ASSAY; CHEMOTHERAPY; FEMALE; FRANCE; HEALTH CARE PERSONNEL; HUMAN; HUMAN EXPERIMENT; INFECTION; INTERFERON GAMMA RELEASE ASSAY; MALE; NORMAL HUMAN; PROBABILITY; SCREENING TEST; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 73849124221     PISSN: None     EISSN: 17456673     Source Type: Journal    
DOI: 10.1186/1745-6673-4-30     Document Type: Article

References (36)

1. Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas. A Seidler A Nienhaus R Diel, Respiration 2005 72 4 431 446 10.1159/000086261 16088290
2. Occupational risk of tuberculosis transmission in a low-incidence area. R Diel A Seidler A Nienhaus S Rusch-Gerdes S Niemann, Respir Res 2005 6 1 35 45 15831092 10.1186/1465-9921-6-35 (Pubitemid 41358035)
3. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Healthcare Settings, 2005. CDC - Center for Disease Control and Prevention, MMWR 2005 54 No RR-17 1 141
4. What does tuberculin reactivity after Bacille Calmette-Guerin vaccination tell us? D Menzies, Clin infect Dis 2000 31 Suppl 3 71 S74 10.1086/314075 11010826
5. Specific immune-based diagnosis of tuberculosis. P Andersen ME Munk JM Pollock TM Doherty, Lancet 2000 356 9235 1099 1104 10.1016/S0140-6736(00)02742-2 11009160
6. Advances in the diagnosis and treatment of tuberculosis. P Nahid M Pai PC Hopewell, Proc Am Thorac Soc 2006 3 103 110 16493157 10.1513/pats.200511-119JH (Pubitemid 43304385)
7. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. M Pai LW Riley JM Colford, Lancet Infect Dis 2004 4 761 776 10.1016/S1473-3099(04)01206-X 15567126
8. Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. D Menzies M Pai G Comstock, Ann Intern Med 2007 146 340 352 17339619
9. Predictive value of a whole-blood IFN-{gamma} assay for the development of active TB disease. R Diel R Loddenkemper K Meywald-Walter S Niemann A Nienhaus, Am J Respir Crit Care Med 2008 177 1164 1170 10.1164/rccm.200711- 1613OC 18276940
10. Screening for tuberculosis infection using whole-blood interferon- and Mantoux testing among Japanese healthcare workers. N Harada Y Nakajima K Higuchi Y Sekiya J Rothel T Mori, Infection control and hospital epidemiology 2006 27 5 442 448 10.1086/504358 (Pubitemid 43835524)
11. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M: tuberculosis specific INF- whole-blood test. B Soberg AB Andersen HK Larsen K Weldingh P Andersen K Kofoerd P Ravn, Scandinavian Journal of Infectious Diseases 2007 39 554 559 10.1080/ 00365540601148483 17577817
12. Usefulness of QuantiFERON TB-2G, a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers. Y Kobashi Y Obase M Fukuda K Yoshida N Miyashita M Fujii M Oka, Intern Med 2007 46 18 1543 9 10.2169/internalmedicine.46.0088 17878640
13. Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia. V Mirtskhulava R Kempker KL Shields MK Leonard T Tsertsvadze C del Rio A Salakaia HM Blumberg, Int J Tuberc Lung Dis 2008 12 5 513 519 18419886
14. Evaluation of the interferon-gamma release assay in healthcare workers. A Nienhaus A Schablon B Siano C le Bacle R Diel, Int Arch Occup Environ Health 2008 81 295 300 10.1007/s00420-007-0212-1 17605033
15. Comparison of the interferon- release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers. SS-J Lee Y-C Liu T-S Huang Y-S Chen H-C Tsai S-R Wann H-H Lin, Scandinavian Journal of Infectious Disease 2008 40 5 373 80 10.1080/00365540701730743 (Pubitemid 351575072)
16. Prevalence of latent tuberculosis infection among healthcare workers in a hospital for pulmonary diseases. A Schablon G Beckmann M Harling R Diel A Nienhaus, J Occup Med Toxicol 2009 4 1 19134168 10.1186/1745-6673-4-1
17. Comparison of QuantiFERON-TB Gold In-Tube test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. P Vinton S Mihrshahi P Johnson GA Jenkin D Jolley BA Biggs, Infection Control and Hospital Epidemiology 2009 30 3 online first
18. In-hospital contact investigation among health care workers after exposure to smear-negative tuberculosis. FC Ringshausen S Schlösser A Nienhaus A Schablon G Schultze-Werninghaus G Rohde, J Occup Med Tox 2009 4 11 10.1186/1745-6673-4-11
19. Investigations conduire autour d'un cas de tuberculose-maladie ou tuberculose-infection récente. French guidelines for TB screening in HCWs, Revue des Maladies Infectieuses 2004 34 391 396
20. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. National Institute for Health and Clinical Excellence, London 2006
21. Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. JP Zellweger A Zellweger S Ansermet B de Senarclens P Wrighton-Smith, Int J Tuberc Lung Dis 2005 9 1242 1247 16333932
22. Recommendations for environmental contact tracing in tuberculosis. German Central Committee against Tuberculosis. R Diel M Forssbohm G Loytved W Haas B Hauer D Maffei K Magdorf A Nienhaus HL Rieder T Schaberg JP Zellweger R Loddenkemper, Gesundheitswesen 2007 69 488 503 10.1055/s-2007-980089 17926267 (Pubitemid 350004828)
23. Tuberculosis in France: New Challenges for the practitioners. D Che N Lefebvre F Antoun P Fraisse M Depinoy D Antoine D Farge MC Paty, La Revue de Médecine Interne 2009 30 142 9 10.1016/j.revmed.2008.07.014
24. Applied Logistic Regression. D Hosmer S Lemeshow, New York, NY: John Wiley & Sons 2000 10886529
25. Nienhaus. Tuberculosis screening in Portuguese healthcare workers using the Tuberculin Skin Test and the Interferon- release assay. J Torres Costa R Sá. MJ Cardoso R Silva J Ferreira C Ribeiro M Miranda JL Plcido, Eur Resp J 2009 34 6 1423 1428 10.1183/09031936.00053809
26. Interferon- release assay for the diagnosis of latent TB infection - analysis of discordant results, when compared to the tuberculin skin test. A Nienhaus A Schablon R Diel, PLoS ONE 2008 3 7 2665 18628829 10.1371/journal. pone.0002665
27. Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school. K Higuchi N Harada T Mori Y Sekiya, Respirology 2007 12 1 88 92 10.1111/j.1440-1843.2006.01000.x 17207031
28. Contact investigation in a primary school using a whole-blood interferon-gamma assay. K Higuchi S Kondo M Wada S Hayashi G Ootsuka N Sakamoto N Harada, I Infect 2009 58 5 352 7 10.1016/j.jinf.2009.02.019
29. Detection and Prediction of Active Tuberculosis Disease by a Whole-Blood Interferon-gamma Release Assay in HIV-1-Infected Individuals. MC Aichelburg A Rieger F Breitenecker K Pfistershammer J Tittes S Eltz AC Aichelburg G Stingl A Makristathis N Kohrgruber, Clin Infect Dis 2009 48 7 954 62 10.1086/597351 19245343
30. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. R Diel A Nienhaus R Loddenkemper, Chest 2007 131 1424 1434 10.1378/chest.06-2728 17494792 (Pubitemid 46762348)
31. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis. R Diel P Wrighton-Smith JP Zellweger, Eur Respir J 2007 30 321 332 10.1183/09031936.00145906 17504793 (Pubitemid 47194185)
32. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. O Oxlade K Schwartzman D Menzies, Int J Tuberc Lung Dis 2007 11 1 16 26 17217125
33. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts. F Marra CA Marra M Sadatsafavi, Int J Tuberc Lung Dis 2008 12 1414 1424 19017451
34. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. MA De Perio J Tsevat GA Roselle, Arch Intern Med 2009 169 179 187 10.1001/archinternmed.2008.524 19171815
35. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? - A TBNET consensus statement. U Mack GB Migliori M Sester HL Rieder S Ehlers D Goletti A Bossink K Magdorf C Hölscher B Kampmann SM Arend A Detjen G Bothamley JP Zellweger H Milburn R Diel P Ravn F Cobelens PJ Cardona B Kann I Solovic R Duarte DM Cirillo C Lange, Eur Respir J 2009 33 956 73 10.1183/09031936.00120908 19407047
36. Persistently elevated T cell interferon- response after treatment for latent tuberculosis infection among healthcare workers in India: a preliminary report. M Pai R Joshi S Dogra DK Mendiratta P Narang K Dheda S Kalantri, Journal of Occupational Medicine and Toxicology 2006 1 7 10.1186/1745-6673-1-7 (Pubitemid 46724442)